U.S. Forensic Genomics Market Size To Reach $941.0 Million By 2033

U.S. Forensic Genomics Market Growth & Trends

The U.S. forensic genomics market size is projected to reach USD 941.0 million by 2033, growing at a CAGR of 15.65% from 2025 to 2030, according to a new report by Grand View Research, Inc. The U.S. forensic genomics market is experiencing robust growth, fueled by the increasing application of advanced genomic technologies in criminal justice, human identification, and investigative efforts. The demand for more accurate, efficient, and high-throughput DNA analysis tools is rising as law enforcement agencies, forensic laboratories, and legal systems seek to enhance case resolution rates, support cold case investigations, and exonerate the wrongly convicted. Innovations in next-generation sequencing (NGS), microarray platforms, and rapid DNA analysis are transforming traditional forensic workflows, enabling the extraction of usable genetic information from highly degraded, trace, or mixed samples.

As genomic databases expand and public-private collaborations intensify, the integration of forensic genomics into routine criminal investigations is becoming more widespread. Technologies such as whole-genome sequencing, mitochondrial DNA analysis, and SNP-based profiling provide higher resolution and discrimination power than conventional STR methods, supporting ancestry inference, kinship analysis, and phenotypic prediction applications. The increasing use of forensic genealogy, particularly in cold case resolution and unidentified remains, underscores the growing utility of genomics beyond standard crime scene processing.

Technological innovation is central to market expansion, with AI-driven data interpretation, DNA extraction, library preparation automation, and cloud-based forensic informatics platforms streamlining laboratory operations. These tools reduce analysis time, improve accuracy, and support compliance with stringent quality control and chain-of-custody requirements. Emerging capabilities, including real-time DNA sequencing and portable devices, enhance field-based forensics and on-site decision-making.

As forensic genomics becomes more deeply embedded in public safety and judicial processes, the U.S. market is set to play a pivotal role in advancing truth and justice. From solving violent crimes and identifying disaster victims to informing counter-terrorism efforts and human trafficking investigations, the sector is critical to modernizing forensic science and reinforcing the criminal justice system's integrity.

 Request a free sample copy or view report summary: U.S. Forensic Genomics Market Report

U.S. Forensic Genomics Market Report Highlights

• Based on product, the kits & consumables segment dominated the U.S. forensic genomics market with the largest revenue share of 67.19% in 2024. This dominance stems from the critical, recurring use of reagents, extraction kits, PCR kits, sequencing consumables, and other lab essentials that enable high-quality DNA analysis across various forensic workflows. As forensic laboratories work to enhance throughput and turnaround times, the demand for reliable and standardized consumables continues to grow, supporting both casework and backlog reduction efforts.

• Based on method, the capillary electrophoresis (CE) segment led the market with a revenue share of 36.98% in 2024. CE remains widely used due to its high accuracy in STR profiling, robust performance with limited or degraded DNA, and strong compatibility with existing forensic databases such as CODIS. Despite the rise of next-generation sequencing (NGS), CE remains a preferred method for core forensic applications, including human identification and kinship testing. Its continued use reflects regulatory familiarity and the widespread infrastructure supporting CE-based workflows in public and private crime labs.

• Based on application, the criminal testing segment was the dominant force in the U.S. forensic genomics market, capturing a substantial revenue share of 66.15% in 2024. Forensic genomics is central to solving violent crimes, property offenses, and cold cases through DNA profiling, database matching, and suspect exclusion or confirmation. With increasing reliance on DNA evidence to support investigations and prosecutions, demand for accurate and efficient genomic tools continues to rise. This segment also benefits from the growing adoption of forensic genealogy and advanced phenotyping to generate investigative leads, expanding the role of genomics in modern law enforcement.

• In May 2025, QIAGEN acquired Israeli AI-driven software company Genoox for USD 70 million, with up to USD 10 million in milestone payments. The deal strengthens QIAGEN’s Digital Insights portfolio by adding Genoox’s Franklin platform, a cloud-based tool used by over 4,000 healthcare organizations in 50+ countries for real-time NGS data analysis. This integration will enhance diagnostic accuracy, speed, and scalability for clinical labs, complementing QIAGEN’s existing solutions like QCI Interpret and QCI Precision Insights.

U.S. Forensic Genomics Market Segmentation

Grand View Research has segmented the U.S. forensic genomics based on product, method, and application.

U.S. Forensic Genomics Product Outlook (Revenue, USD Million, 2021 - 2033)

• Analyzers & Sequencers

• Software

• Kits & Consumables

U.S. Forensic Genomics Method Outlook (Revenue, USD Million, 2021 - 2033)

• Capillary Electrophoresis

• Next-generation Sequencing

• PCR Amplification

• Others

U.S. Forensic Genomics Application Outlook (Revenue, USD Million, 2021 - 2033)

• Criminal Testing

• Paternity & Familial Testing

• Others 

List of Key Players in the U.S. Forensic Genomics Market

• Illumina, Inc.

• Thermo Fisher Scientific, Inc.

• Merck KGaA

• Agilent Technologies

• Promega Corporation

• QIAGEN

• Bio-Rad Laboratories

• LGC Limited

• Tri Tech Forensics

• Verogen